Literature DB >> 26204823

Deletion of SPRY4 is a frequent event in secondary acute myeloid leukemia.

Olivia Geiger1, Stefan Hatzl1, Karl Kashofer2, Gerald Hoefler2, Albert Wölfler1, Heinz Sill1, Armin Zebisch3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26204823      PMCID： PMC5024751          DOI： 10.1007/s00277-015-2445-5

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  7 in total

1.  Diagnosis of haploidy and triploidy based on measurement of gene copy number by real-time PCR.

Authors:  K Wilke; B Duman; J Horst
Journal:  Hum Mutat       Date:  2000-11       Impact factor: 4.878

2.  Are mouthwashes a reliable source of constitutional DNA in patients with leukemia?

Authors:  Armin Zebisch; Heinz Sill
Journal:  Leuk Res       Date:  2007-12-21       Impact factor: 3.156

3.  Frequent loss of RAF kinase inhibitor protein expression in acute myeloid leukemia.

Authors:  A Zebisch; A Wölfler; I Fried; O Wolf; K Lind; C Bodner; M Haller; A Drasche; D Pirkebner; D Matallanas; O Rath; K Blyth; R Delwel; E Taskesen; F Quehenberger; W Kolch; J Troppmair; H Sill
Journal:  Leukemia       Date:  2012-03-05       Impact factor: 11.528

4.  Two transforming C-RAF germ-line mutations identified in patients with therapy-related acute myeloid leukemia.

Authors:  Armin Zebisch; Philipp B Staber; Ali Delavar; Claudia Bodner; Karin Hiden; Katja Fischereder; Manickam Janakiraman; Werner Linkesch; Holger W Auner; Werner Emberger; Christian Windpassinger; Michael G Schimek; Gerald Hoefler; Jakob Troppmair; Heinz Sill
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

5.  Loss of RAF kinase inhibitor protein is a somatic event in the pathogenesis of therapy-related acute myeloid leukemias with C-RAF germline mutations.

Authors:  A Zebisch; M Haller; K Hiden; T Goebel; G Hoefler; J Troppmair; H Sill
Journal:  Leukemia       Date:  2009-04-09       Impact factor: 11.528

6.  Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.

Authors:  Timothy J Ley; Christopher Miller; Li Ding; Benjamin J Raphael; Andrew J Mungall; A Gordon Robertson; Katherine Hoadley; Timothy J Triche; Peter W Laird; Jack D Baty; Lucinda L Fulton; Robert Fulton; Sharon E Heath; Joelle Kalicki-Veizer; Cyriac Kandoth; Jeffery M Klco; Daniel C Koboldt; Krishna-Latha Kanchi; Shashikant Kulkarni; Tamara L Lamprecht; David E Larson; Ling Lin; Charles Lu; Michael D McLellan; Joshua F McMichael; Jacqueline Payton; Heather Schmidt; David H Spencer; Michael H Tomasson; John W Wallis; Lukas D Wartman; Mark A Watson; John Welch; Michael C Wendl; Adrian Ally; Miruna Balasundaram; Inanc Birol; Yaron Butterfield; Readman Chiu; Andy Chu; Eric Chuah; Hye-Jung Chun; Richard Corbett; Noreen Dhalla; Ranabir Guin; An He; Carrie Hirst; Martin Hirst; Robert A Holt; Steven Jones; Aly Karsan; Darlene Lee; Haiyan I Li; Marco A Marra; Michael Mayo; Richard A Moore; Karen Mungall; Jeremy Parker; Erin Pleasance; Patrick Plettner; Jacquie Schein; Dominik Stoll; Lucas Swanson; Angela Tam; Nina Thiessen; Richard Varhol; Natasja Wye; Yongjun Zhao; Stacey Gabriel; Gad Getz; Carrie Sougnez; Lihua Zou; Mark D M Leiserson; Fabio Vandin; Hsin-Ta Wu; Frederick Applebaum; Stephen B Baylin; Rehan Akbani; Bradley M Broom; Ken Chen; Thomas C Motter; Khanh Nguyen; John N Weinstein; Nianziang Zhang; Martin L Ferguson; Christopher Adams; Aaron Black; Jay Bowen; Julie Gastier-Foster; Thomas Grossman; Tara Lichtenberg; Lisa Wise; Tanja Davidsen; John A Demchok; Kenna R Mills Shaw; Margi Sheth; Heidi J Sofia; Liming Yang; James R Downing; Greg Eley
Journal:  N Engl J Med       Date:  2013-05-01       Impact factor: 91.245

7.  Cooperative loss of RAS feedback regulation drives myeloid leukemogenesis.

Authors:  Zhen Zhao; Chi-Chao Chen; Cory D Rillahan; Ronglai Shen; Thomas Kitzing; Megan E McNerney; Ernesto Diaz-Flores; Johannes Zuber; Kevin Shannon; Michelle M Le Beau; Mona S Spector; Scott C Kogan; Scott W Lowe
Journal:  Nat Genet       Date:  2015-03-30       Impact factor: 38.330
  7 in total
  4 in total

Review 1.  RASopathy Gene Mutations in Melanoma.

Authors:  Ruth Halaban; Michael Krauthammer
Journal:  J Invest Dermatol       Date:  2016-05-25       Impact factor: 8.551

2.  Acute myeloid leukemia with TP53 germ line mutations.

Authors:  Armin Zebisch; Ridhima Lal; Marian Müller; Karin Lind; Karl Kashofer; Michael Girschikofsky; David Fuchs; Albert Wölfler; Jochen B Geigl; Heinz Sill
Journal:  Blood       Date:  2016-09-12       Impact factor: 22.113

3.  Loss of RAF kinase inhibitor protein is involved in myelomonocytic differentiation and aggravates RAS-driven myeloid leukemogenesis.

Authors:  Veronica Caraffini; Olivia Geiger; Angelika Rosenberger; Stefan Hatzl; Bianca Perfler; Johannes L Berg; Clarice Lim; Herbert Strobl; Karl Kashofer; Silvia Schauer; Christine Beham-Schmid; Gerald Hoefler; Klaus Geissler; Franz Quehenberger; Walter Kolch; Dimitris Athineos; Karen Blyth; Albert Wölfler; Heinz Sill; Armin Zebisch
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941

4.  Increased Expression of miR-23a Mediates a Loss of Expression in the RAF Kinase Inhibitor Protein RKIP.

Authors:  Stefan Hatzl; Olivia Geiger; Maja Kim Kuepper; Veronica Caraffini; Till Seime; Tobias Furlan; Erika Nussbaumer; Rotraud Wieser; Martin Pichler; Marcel Scheideler; Katarzyna Nowek; Mojca Jongen-Lavrencic; Franz Quehenberger; Albert Wölfler; Jakob Troppmair; Heinz Sill; Armin Zebisch
Journal:  Cancer Res       Date:  2016-04-15       Impact factor: 12.701
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.